User login
Dr. William Wierda discusses ofatumumab, an investigational monoclonal antibody that targets B cells and has been studied in the treatment of chronic lymphocytic leukemia. Mitchel Zoler of the Global Medical News Network (GMNN) reports from the annual congress of the European Hematology Association in Berlin.
Dr. William Wierda discusses ofatumumab, an investigational monoclonal antibody that targets B cells and has been studied in the treatment of chronic lymphocytic leukemia. Mitchel Zoler of the Global Medical News Network (GMNN) reports from the annual congress of the European Hematology Association in Berlin.
Dr. William Wierda discusses ofatumumab, an investigational monoclonal antibody that targets B cells and has been studied in the treatment of chronic lymphocytic leukemia. Mitchel Zoler of the Global Medical News Network (GMNN) reports from the annual congress of the European Hematology Association in Berlin.